Actuate Therapeutics, Inc. Common stock (ACTU) Stock Price
Actuate Therapeutics, Inc. Common stock (NASDAQ: ACTU) last traded at $1.27, up 3.25% on the session. The quote above updates while this page is open; the figures below are drawn from Actuate Therapeutics, Inc. Common stock’s own filings and are restated only when a new one is published.
Actuate Therapeutics, Inc. Common stock (ACTU) company overview
Actuate Therapeutics, Inc. Common stock trades on NASDAQ under the ticker ACTU. Its market capitalisation is $30.50 million.
ACTU valuation
Valuation measures for Actuate Therapeutics, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
Market cap
$30.50M
Enterprise value
$30.28M
Price / book
30.83
Beta
1.72
ACTU financials
Trailing-twelve-month figures tagged in Actuate Therapeutics, Inc. Common stock's XBRL filings with the SEC.
Net income (TTM)
-$20.45M
EPS (TTM)
-$0.880
Return on equity
-2067.81%
Cash
$4.43M
ACTU trading statistics
Range and volume for ACTU over the past 52 weeks.
52-week high
$9.22
52-week low
$0.900
Volume
264.2K
Average volume
281.2K
Previous close
$1.23
Actuate Therapeutics, Inc. Common stock (ACTU) FAQs
What is the ACTU stock price today?
Actuate Therapeutics, Inc. Common stock (ACTU) last traded at $1.27, up 3.25% on the session. FurlPay quotes ACTU from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is ACTU listed on?
Actuate Therapeutics, Inc. Common stock is listed on NASDAQ under the ticker symbol ACTU.
What is Actuate Therapeutics, Inc. Common stock's market cap?
Actuate Therapeutics, Inc. Common stock has a market capitalisation of $30.50 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is ACTU's 52-week range?
Over the past 52 weeks ACTU has traded between $0.90 and $9.22.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001652935), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
ACTU Stock Price & Quote | Actuate Therapeutics, Inc. Common stock | FurlPay